Preliminary considerations on the application of the voice handicap index to paediatric dysphonia

A Schindler1, P Capaccio, P Maruzzi

  • 1Department of Clinical Sciences L. Sacco, University of Milan, Italy. antonio.schindler@tiscali.it

Insights

The Voice Handicap Index effectively measured improvements in children with dysphonia after voice therapy. This self-assessment tool is valuable for pediatric voice disorders, though a specialized version is needed.

Area of Science:

  • Pediatric Otolaryngology
  • Speech-Language Pathology
  • Voice Science

Background:

  • Dysphonia is a common childhood condition.
  • Standard adult voice assessment includes endoscopy, aerodynamics, acoustics, perception, and self-assessment.
  • The Voice Handicap Index (VHI) is a widely used self-assessment tool, but its pediatric application is undocumented.

Purpose of the Study:

  • To evaluate VHI ratings in dysphonic children before and after voice therapy.
  • To assess the applicability and effectiveness of the VHI in a pediatric population.
  • To explore correlations between VHI domains and objective voice measures.

Main Methods:

  • A cohort of 28 children (mean age 10.9 years) with chronic hoarseness (vocal fold nodules, edema, or paralysis) underwent 5-6 months of voice therapy.
  • Multi-modal voice assessments included video-endoscopy, maximum phonation time, GIRBAS scale, spectrograms, perturbation analysis, and the VHI.
  • Statistical analysis involved Wilcoxon's test, Student's t test, and Pearson's correlation coefficient.

Main Results:

  • Significant improvement in VHI scores (p = 0.0006) was observed post-therapy.
  • Objective measures showed decreased nodules/edema in 18 children and improved glottic closure in 2 with paralysis.
  • Jitter values showed a significant improvement (p = 0.016), while other acoustic and perceptual measures showed non-significant trends.

Conclusions:

  • The Voice Handicap Index is a valuable and applicable tool for assessing dysphonic children.
  • Voice therapy led to significant improvements in self-perceived voice handicap.
  • An adapted and validated VHI version for pediatric patients is essential for optimal clinical use.